Correlation Between Edgewise Therapeutics and Immunocore Holdings
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Immunocore Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Immunocore Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Immunocore Holdings, you can compare the effects of market volatilities on Edgewise Therapeutics and Immunocore Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Immunocore Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Immunocore Holdings.
Diversification Opportunities for Edgewise Therapeutics and Immunocore Holdings
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Edgewise and Immunocore is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Immunocore Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunocore Holdings and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Immunocore Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunocore Holdings has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Immunocore Holdings go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Immunocore Holdings
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 2.04 times more return on investment than Immunocore Holdings. However, Edgewise Therapeutics is 2.04 times more volatile than Immunocore Holdings. It trades about 0.08 of its potential returns per unit of risk. Immunocore Holdings is currently generating about -0.03 per unit of risk. If you would invest 678.00 in Edgewise Therapeutics on December 12, 2024 and sell it today you would earn a total of 1,978 from holding Edgewise Therapeutics or generate 291.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Immunocore Holdings
Performance |
| Timeline |
| Edgewise Therapeutics |
| Immunocore Holdings |
Edgewise Therapeutics and Immunocore Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Immunocore Holdings
The main advantage of trading using opposite Edgewise Therapeutics and Immunocore Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Immunocore Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunocore Holdings will offset losses from the drop in Immunocore Holdings' long position.| Edgewise Therapeutics vs. Century Therapeutics | ||
| Edgewise Therapeutics vs. C4 Therapeutics | ||
| Edgewise Therapeutics vs. Mineralys Therapeutics, Common | ||
| Edgewise Therapeutics vs. Cullinan Oncology LLC |
| Immunocore Holdings vs. Arcellx | ||
| Immunocore Holdings vs. Ventyx Biosciences | ||
| Immunocore Holdings vs. Vaxcyte | ||
| Immunocore Holdings vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |